Alan A Musso

CIK 1295830 · Chief Financial Officer · last filed 2026-02-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

47

Lifetime Open-Market Net

-$1.45M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FULC Chief Financial Officer $3.45 $0 5 2026-02-04
RNTX Director $0.96 $0 1 2025-07-23
Rein Therapeutics, Inc. (ALRN) Delisted Director $2.11 $0 3 2024-12-06
BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted CFO and Treasurer 26,548 $0.07 $2.0K -$1.45M 14 2018-07-05

Recent Filings · Page 3 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-11-27 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Sell (S) −29,300 -$654.5K EDGAR
2015-02-26 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Grant (A) $0 EDGAR
2014-12-22 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Grant (A) +117,647 $0 EDGAR
2014-10-21 Grant (A) +55,000 $0
2014-01-24 Grant (A) $0
2013-01-18 Grant (A) $0
2012-05-08 Grant (A) $0
2011-06-08 Mixed -$506.6K
2011-03-31 Grant (A) $0
2010-12-23 Mixed -$438.5K
Showing 2130 of 47
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.